These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16870507)

  • 1. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.
    Rivas JM; Speziale P; Patti JM; Höök M
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):223-7. PubMed ID: 15603256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination and passive immunisation against Staphylococcus aureus.
    Schaffer AC; Lee JC
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T; Farnebo F; Szekely L; Flock JI
    APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
    John CC; Schreiber JR
    Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 16. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.
    Dayan GH; Mohamed N; Scully IL; Cooper D; Begier E; Eiden J; Jansen KU; Gurtman A; Anderson AS
    Expert Rev Vaccines; 2016 Nov; 15(11):1373-1392. PubMed ID: 27118628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections.
    Flock JI
    Mol Med Today; 1999 Dec; 5(12):532-7. PubMed ID: 10562719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.
    Lucero CA; Hageman J; Zell ER; Bulens S; Nadle J; Petit S; Gershman K; Ray S; Harrison LH; Lynfield R; Dumyati G; Townes JM; Schaffner W; Fridkin SK;
    Vaccine; 2009 Aug; 27(37):5061-8. PubMed ID: 19576943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus.
    Roth DM; Senna JP; Machado DC
    Genet Mol Res; 2006 Aug; 5(3):503-12. PubMed ID: 17117366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.